Patents by Inventor Gemma Lancaster

Gemma Lancaster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9907507
    Abstract: The present invention relates to a method of diagnosing, or providing a prognosis to, or for providing the likelihood of developing, malignant melanoma in a subject, the method comprising the steps of: (a) measuring two or more markers in blood perfusion dynamics at and/or around a skin lesion site; and (b) determining if the two or more markers is different to a normal value. The invention also relates to a device for diagnosing/providing a prognosis to/for malignant melanoma in a subject.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: March 6, 2018
    Assignee: Lancaster University Business Enterprises Limited
    Inventors: Gemma Lancaster, Aneta Stefanovska, Marco Rossi, Margherita Pesce
  • Publication number: 20160007907
    Abstract: The present invention relates to a method of diagnosing, or providing a prognosis to, or for providing the likelihood of developing, malignant melanoma in a subject, the method comprising the steps of: (a) measuring two or more markers in blood perfusion dynamics at and/or around a skin lesion site; and (b) determining if the two or more markers is different to a normal value. The invention also relates to a device for diagnosing/providing a prognosis to/for malignant melanoma in a subject.
    Type: Application
    Filed: July 11, 2014
    Publication date: January 14, 2016
    Inventors: Gemma Lancaster, Aneta Stefanovska, Marco Rossi, Margherita Pesce